Form 4: Protagonist Therapeutics CEO Dinesh Patel Gifts 1,000 Shares of Common Stock

Sentiment:

SEC Form 4 Filing


Dinesh V. Patel, CEO of Protagonist Therapeutics, gifted 1,000 shares of common stock to his grandchild on June 13, 2024.

Summary

  • On June 13, 2024, Dinesh V. Patel, the President and CEO of Protagonist Therapeutics, Inc., gifted 1,000 shares of the company's common stock.
  • The transaction was a bona fide gift to his grandchild.
  • Following the transaction, Patel directly owns 514,415 shares of Protagonist Therapeutics.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing regarding a gift of shares. It doesn't inherently convey positive or negative sentiment about the company's performance or prospects.

Industry Context

This is a routine disclosure of a transaction by a company insider and doesn't necessarily reflect broader industry trends.

Stakeholder Impact

  • The gift of shares has a negligible impact on shareholders, employees, customers, suppliers, and creditors.

Key Dates

DateDescription
06/13/2024Date of the gift transaction of 1,000 shares of common stock.
06/17/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.